MARKET

FBLG

FBLG

Fibrobiologics
NASDAQ
0.2587
-0.0022
-0.84%
Opening 11:56 12/19 EST
OPEN
0.2570
PREV CLOSE
0.2609
HIGH
0.2650
LOW
0.2515
VOLUME
403.34K
TURNOVER
--
52 WEEK HIGH
2.510
52 WEEK LOW
0.2353
MARKET CAP
17.21M
P/E (TTM)
-0.5380
1D
5D
1M
3M
1Y
5Y
1D
FibroBiologics Inc. Announces Date for Upcoming Special Meeting of Stockholders
Reuters · 1d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 1d ago
Vanguard Total Stock Market ETF (VTI) Daily Update—12/17/25
TipRanks · 2d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 2d ago
FIBROBIOLOGICS ANNOUNCES CLOSING OF $1.7 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Reuters · 2d ago
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Barchart · 3d ago
Vanguard Total Stock Market ETF (VTI) Daily Update—12/16/25
TipRanks · 3d ago
FibroBiologics Enters Securities Purchase Agreement
TipRanks · 3d ago
More
About FBLG
FibroBiologics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). It is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat multiple sclerosis (MS) and has completed the Phase I study. It is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing. Its CYPS317 is used for the treatment of Psoriasis.

Webull offers Fibrobiologics Inc stock information, including NASDAQ: FBLG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBLG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBLG stock methods without spending real money on the virtual paper trading platform.